Make 2013 the year of understanding...
January 1, 2013...understanding, that is, the very great differences between omega-3s and omega-6s.
What follows is the abstract for one of the most telling studies published in 2012. By a Harvard researcher, the study shows the differing effects of dietary omega -3s and omega-6s on the ability of tumors to form new blood vessels. Omega-6s promote this necessary step in tumor growth and omega-3s inhibit it!
Please read and pass this along.
Also, please follow me on twitter (SusanAllport) since it is often easier for me to post quick tweets on omega-3s than create a newsletter.
Thank you and a Happy New Year to you all!
Cancer Metastasis Rev. 2012 Oct 23. [Epub ahead of print]
The role of the tissue omega-6/omega-3 fatty acid ratio in regulating tumor angiogenesis.
Kang JX, Liu A.
Harvard Medical School, Boston, MA, USA, firstname.lastname@example.org.
Angiogenesis is a necessary step in tumor growth and metastasis. It is well established that the metabolites of omega-6 and omega-3 fatty acids, which must be obtained through the diet and cannot be synthesized de novo in mammals, have differential effects on cellular processes. Omega-6 fatty acid (n-6 FA)-derived metabolites promote angiogenesis by increasing growth factor expression whereas omega-3 fatty acids (n-3 FA) have anti-angiogenic and antitumor properties. However, most studies thus far have failed to account for the role of the n-6 FA/n-3 FA ratio in angiogenesis and instead examined the absolute levels of n-6 and n-3 FA. This review highlights the biochemical interactions between n-6 and n-3 FA and focuses on how the n-6/n-3 FA ratio in tissues modulates tumor angiogenesis. We suggest that future work should consider the n-6/n-3 FA ratio to be a key element in experimental design and analysis. Furthermore, we recommend that clinical interventions should aim to both reduce n-6 metabolites and simultaneously increase n-3 FA intake.
PMID: 23090260 [PubMed - as supplied by publisher]